logo
Select company
Select metric
38.91%Cost of Revenue Margin
VS
Market
61
Sector
41
Industry
51
History
26
$ 7.49Close
$ 2.22 - $ 7.49 52-Week Range
Ticker Information

Ticker

AQST

Company Name

AQUESTIVE THERAPEUTICS INC

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NASDAQ

AQUESTIVE THERAPEUTICS INC - Cost of Revenue Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

AQST - COGS % Historical data
DateCost of RevenueCost of Revenue MarginRevenues
6/30/2025$ 17.17M38.91%$ 44.13M
3/31/2025$ 17.14M31.6%$ 54.23M
12/31/2024$ 17.87M31.05%$ 57.56M
9/30/2024$ 18.03M30.61%$ 58.9M
6/30/2024$ 18.39M31.51%$ 58.36M
3/31/2024$ 20.48M39.77%$ 51.5M
12/31/2023$ 20.83M41.18%$ 50.58M
9/30/2023$ 21.46M44.65%$ 48.06M
6/30/2023$ 21.28M45.75%$ 46.52M
3/31/2023$ 19.91M42.77%$ 46.54M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • AQUESTIVE THERAPEUTICS INC's latest trailing twelve months (TTM) COGS % stands at 30.78%.
  • Over the past 5 years, AQUESTIVE THERAPEUTICS INC's average COGS % has been 34.81%.
  • The median COGS % for AQUESTIVE THERAPEUTICS INC during this period was 31.62%
  • AQUESTIVE THERAPEUTICS INC reached its highest COGS % over the past 5 years at 45.75%.
  • The lowest COGS % recorded by AQUESTIVE THERAPEUTICS INC in the same timeframe 25.02%

AQUESTIVE THERAPEUTICS INC's COGS % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

COGS % Benchmarks
CompanyCOGS %
ETON : ETON PHARMACEUTICALS INC 39.84%TKNO : ALPHA TEKNOVA INC 76.34%XOMA : XOMA ROYALTY CORP 0%DERM : JOURNEY MEDICAL CORP 30.59%CPIX : CUMBERLAND PHARMACEUTICALS INC 16.01%SNWV : SANUWAVE HEALTH INC 22.31%GOSS : GOSSAMER BIO INC 0%SMLR : SEMLER SCIENTIFIC INC 9.15%LXRX : LEXICON PHARMACEUTICALS INC 0.82%SCPH : SCPHARMACEUTICALS INC 31.54%

Definition of Cost of Revenue Margin

[Calculation] The Cost of Revenue [CoR] expressed as a percentage of [Revenue]. Also named Cost Revenue Ratio.
COGS / Revenues
(=) COGS %
COGS % for AQUESTIVE THERAPEUTICS INC is calculated as follows: COGS [ $ 16.97M ] / Revenues [ $ 55.12M ]
(=) COGS % [ 30.78% ]

AQST - Cost of Revenue Margin, Last 5 years

25.02%

Minimum

Mar 31, 2021

45.75%

Maximum

Jun 30, 2023

34.81%

Average

31.62%

Median

COGS % Benchmark Analysis

The chart above depicts the distribution of COGS % for companies in the Total Stock Market. The average COGS % of the companies is 46.91% with a standard deviation of 31.59%.
The following table provides additional summary stats:
COGS % in the Market:
filtered constituents3.81K
min-50.26%
max172.25%
average46.91%
median50.54%
std31.59%